crd vs. met in patients with obese pcos infertility

Conditions: Polycystic Ovary Syndrome

Summary: polycystic ovary syndrome (pcos) is a common gynecological endocrine disease and a major cause of anovulatory infertility in reproductive-aged women. from 2010 to 2020, it was found that the prevalence of pcos in reproductive-aged women in china reached 7.8%, an increase of 65% over 10 years ago. many of them are overweight or obese. weight loss including diet modifications can significantly reduce reproductive and metabolic disorders of pcos and is recommended as a first step in the treatment of overweight or obese women with pcos. many weight loss programs have been proposed, including calorie-restriction diet (crd) intervention. whether crd intervention prior to ovulation induction therapy could improve live birth rates in overweight/obese pcos women has not been illustrated.

polycystic ovary syndrome (pcos) is a common gynecological endocrine disease and a major cause of anovulatory infertility in reproductive-aged women. rotterdam criteria state the definition of pcos is that women must present with two of the following three signs/symptoms-hyperandrogenism, chronic anovulation/oligomenorrhea, and polycystic ovaries-in the absence of other diseases that promote these symptoms. from 2010 to 2020, it was found that the prevalence of pcos in reproductive-aged women in china reached 7.8%, an increase of 65% over 10 years ago. many of them are overweight or obese. weight loss including diet modifications can significantly reduce reproductive and metabolic disorders of pcos and is recommended as a first step in the treatment of overweight or obese women with pcos. many weight loss programs have been proposed, including calorie-restriction diet (crd) intervention. whether crd intervention prior to ovulation induction therapy could improve live birth rates in overweight/obese pcos women has not been illustrated. this research is aimed to evaluate whether crd intervention prior to ovulation induction could promote reproductive health in overweight or obese pcos women with fertility requirements and provide an evidence-based nutrition advice for clinical practice.

Eligibility criteria:
inclusion criteria: 1. a diagnosis of polycystic ovary syndrome (pcos) based on the rotterdam diagnostic criteria; 2. age 20-35 years old; 3. a body-mass index over 23; 4. have requirements for fertility. exclusion criteria: 1. acute or chronic viral hepatitis; 2. serious liver dysfunction or chronic kidney disease; 3. serious cardiovascular or cerebrovascular disease; 4. patients with a history of acute/chronic infection, severe cardiovascular and cerebrovascular diseases, and malignant tumors; 5. have drugs for pcos such as glucocorticoids and anti-androgen drugs (spironolactone, cyproterone acetate, flutamide, etc.) within 3 months; 6. congenital or secondary uterine abnormalities; 7. use of medications that affect weight or energy balance such as metformin within 3 months; 8. undergoing weight loss treatment (weight change greater than 5% in the past 3 months) or have a history of gastrointestinal surgery; 9. tubal obstruction; 10. the total number of motile sperm of male partner is less than 10 million; 11. any other situations that might affect the trial.